Amp 1q21 is more predictable with dismal survival than gain 1q21 of newly diagnosed multiple myeloma in real‐world analysis

INTRODUCTION: The gain/amplification (amp) of 1q21 is one of the most common high‐risk chromosome abnormality (HRCA) in multiple myeloma (MM). The prognostic value of 1q21+ remains to be controversial on the status of gain or amp and the combination of other HRCAs. METHODS: In this retrospective stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yu‐tong, Bao, Li, Chu, Bin, Chen, Xiao‐huan, Lu, Min‐qiu, Shi, Lei, Gao, Shan, Fang, Li‐juan, Xiang, Qiu‐qing, Ding, Yue‐hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280004/
https://www.ncbi.nlm.nih.gov/pubmed/35353920
http://dx.doi.org/10.1002/jcla.24375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280004/
https://www.ncbi.nlm.nih.gov/pubmed/35353920
http://dx.doi.org/10.1002/jcla.24375

Ejemplares similares